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Causes of Stroke 
William M. Landau, MD 
The abstract of the paper “Etiology of Motor or Sensory 
Stroke”[l] follows the text in declaring that “the causes of 
ischemic stroke in the other 81 patients were penetrating 
artery disease (32 patients), large artery occlusive disease 
(17), cardioembolism (12), other causes (8), and undeter- 
mined (12).” No clinicdpathological correlation is offered 
for any of the cases in this series. The authors presume that 
any cardiac abnormality establishes the cardiac came of a small 
cerebral infarction. With no better evidence, small deep le- 
sions not associated with the cardiac disease process are held 
to be cazrsed by penetrating artery disease, unless they are 
larger than 2 cm when they become “stroke of undetermined 
cause.” 
The dictionary definition of cause is “something that brings 
about an effect or result.” I believe that this should be a 
sacred word in scientific writing, not an ought-to-be or might- 
be relationship. Terms such as “phenomenon,” “correlated 
finding,” “risk factor,” and “possible cause” are not equiva- 
lent. There is ample evidence [2-51 that small holes in the 
brain may derive from more than one mechanism. 
The authors’ last page confession that “recognition of a 
vascular lesion does not constitute proof that the lesion 
caused the patient’s stroke” seems to deny their own conclu- 
sion. If we are ever to learn anything about the pathogenesis 
of cerebrovascular disease, I believe that both authors and 
editors will have to insist upon phenomenological and logical 
criteria equivalent to Koch‘s postulates for infectious disease 
[61. 
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Reply 
Marc I. Chimowitz, MD,’ and Anthony J. Furlan, MDt 
One of the major responsibilities of clinicians, when faced 
with patients with cerebrovascular disease, is to identify vas- 
cular lesions for which specific stroke preventive therapy can 
be instituted, e.g., carotid endarterectomy for symptomatic 
high-grade carotid stenosis, and anticoagulation for cardiac 
lesions that predispose to embolism. 
Fisher [ l ,  2 )  has suggested that, in patients presenting with 
pure sensory stroke or pure motor hemiparesis, it is unneces- 
sary to search for carotid stenosis or a cardiac lesion because 
these syndromes are invariably caused by penetrating artery 
disease. Other authors strongly disagree [3, 41. We tested 
Fisher’s hypothesis by performing brain computed tomogra- 
phy or magnetic resonance imaging, echocardiography, and 
cerebrovascular imaging in consecutive patients with motor 
or sensory stroke { 5 ] .  Diagnostic classification was based on 
the results of these in vivo studies. Nonetheless, we failed 
to satisfy Dr Landau’s penchant for diagnostic precision ulti- 
mately, it seems, because we were forced to deal with living 
patients. 
In our study, if a patient did not have a well-established 
cardiac source of embolism (not any cardiac abnormality as 
Dr Landau suggests), proximal large artery occlusive disease 
(>50% stenosis), or another identifiable cause for a small 
(<2cm) subcortical infarct, we attributed the cause of stroke 
to penetrating artery disease. For readers, like Dr Landau, 
who find the label “penetrating artery disease” objectionable 
because of the lack of pathological data, we suggest a descrip- 
tive term such as “small subcortical stroke that is not associ- 
ated with a cardioembolic source, proximal large artery occlu- 
sive disease, or other identifiable cause.” 
We found that pure sensory stroke and pure motor hemi- 
paresis (F = A = L) associated with subcortical infarction less 
than 1.5 cm were predictive ofpenetrating artery disease (or, 
if the readers prefer, the absence of another potential cause) 
in over 90% of cases. These results do not refute the obvious 
fact that “small holes in the brain may derive from more than 
one mechanism,” but they strongly support Fisher’s original 
hypothesis that causes other than penetrating artery disease 
are unusual. The clinical implication of these findings is that 
invasive and expensive procedures such as cerebral angiogra- 
phy and echocardiography are not warranted in patients with 
these syndromes. 
Our “confession” that some of the strokes that we attrib- 
uted to 50 to 60% carotid stenosis or  a cardioembolic source 
may actually have been caused by penetrating artery disease 
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strengthens rather than weakens our conclusions because the 
design of the study was biased (intentionally) toward attribut- 
ing the cause of stroke in these patients to cardioembolic or 
large artery occlusive mechanisms. 
Dr Landau correctly asserts that we have not proven that 
penetrating artery disease per se causes the small, deep in- 
farcts as defined. Logic dictates, however, that until we can 
image arteriolar wall pathology in vivo, circumstantial evi- 
dence such as ours is more useful clinically than quixotic 
ruminations on Koch‘s postulates for stroke. 
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Collapsing Borders? 
James Perry, MD 
In the face of widespread political and territorial change in 
our world, it is interesting to examine the meeting notices in 
recent issues of the Annals. Listed under “meetings outside 
North America” have been no less than four events being 
held in Canada, including the American Neurological Associ- 
ation annual meeting. 
Is this a reflection of world change, pro-Americanism, or 
just bad geography? Unfortunately, according to my Chair- 
man, this new interpretation of continental boundaries does 
not qualify me for foreign travel grants to Montreal or Win- 
nipeg. 
University of Toronto 
Toronto, Ontario, Canada 
Reply 
A. K. Asbury, MD 
Dr Perry is correct. Annals has erred. Borders have not col- 
lapsed, but our alertness has. May our colleagues in Canada 
be moved to forgiveness. 
Editor, Annals of Neurology 
Mitochondrial DNA 
Mutation and Leigh‘s 
Syndrome 
Ryoichi Sakuta, MD,” Yu-ichi Goto, MD,’ 
Satoshi Horai, MD,? Tatsuya Ogino, MD,S 
Harumi Yoshinaga, MD,$ Shunsuke Ohtahara, MD,$ 
and Ikuya Nonaka, MD’ 
Leigh’s syndrome, a progressive neurodegenerative disorder 
with preferential involvement of the basal ganglia, is a group 
of heterogeneous metabolic disorders that includes deficien- 
cies in pyruvate dehydrogenase complex (PDHC), cyto- 
chrome c oxidase (COX), and NADH-coenzyme Q reduc- 
tase. In this communication we describe a patient with Leigh‘s 
syndrome with a maternally transmitted mitochondrial (mt) 
DNA mutation. 
After Tatuch and coworkers [ 11 reported mtDNA muta- 
tion from T to G at position 8993 within the ATPase 6 gene 
in a female infant with Leigh’s syndrome and her mother, 
we examined mtDNA in muscle biopsy specimens from 23 
patients with the clinical characteristics of Leigh’s syndrome 
to determine whether this mutation is a common abnormality 
in this disorder. Among our patients, one had NADH- 
coenzyme Q reductase deficiency, whereas 6 had COX defi- 
ciency and 16 had no identifiable enzyme defect. 
mtDNA in the region from positions 8838 to 9017 within 
the ATPase 6 gene was amplified by polymerase chain reac- 
tion and digested with the restriction enzyme HpaII. Since 
the 8993 mutation created a HgaII recognition site (CCTG 
to CCGG), the 179-base PCR products harboring the muta- 
tion were cleaved into 15 5- and 24-base fragments. With this 
procedure, we detected the mutation in 1 of 23 patients 
in heteroplasmic fashion. In a previous study on mtDNA 
restriction analysis, there was no recognition site of HpaII at 
position 8993 in 116 normal Japanese subjects [Z). 
A 7-year-old girl with this mutation had hypotonia, psycho- 
motor regression, kinetic mutism, choreoathetosis, and re- 
spiratory abnormalities since early infancy with lactic acidosis 
and symmetrical low-density areas in the basal ganglia on 
computed tomography scan. N o  ragged-red fibers were seen 
in her muscle biopsy but COX activity was diffusely de- 
creased. Except for mildly decreased COX activity, no bio- 
chemical defects were found. An identical mutation was 
found in her blood sample as well as in her mother’s, sug- 
gesting a maternal inheritance (Fig). The ratio of mutant 
mtDNA calculated densitometrically on PCR products was 
56.6% in the patient’s blood cells and 4.8% in her mother’s. 
mtDNA mutation at position 8993 in heteroplasmic distri- 
bution has also been described in 4 members of a family who 
had a variable combination of developmental delay, retinitis 
pigmentosa, dementia, seizures, ataxia, proximal neurogenic 
muscle weakness, and sensory neuropathy 131. It would ap- 
pear, therefore, that this mutation is probably responsible 
for some neurological disorders with a maternal inheritance 
pattern, including Leigh’s syndrome 
This point mutation leads to an amino acid change from a 
highly conserved leucine to arginine in ATPase subunit 6, 
thus probably causing failure in ATP synthesis. Because the 
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